Related Experiment Video
Updated: Jul 9, 2026
06:46
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
Published on: February 25, 2022
Integrative Transcriptomics Across Etiologies Reveals Common and Disease-Specific Fibrogenic Signatures in Liver
Wenyan Yang1, Long Li2, Yamei Ye1
1Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China, fjmu.edu.cn.
Canadian Journal of Gastroenterology & Hepatology
|July 8, 2026
Summary
This study identified seven key genes shared across different causes of liver fibrosis, offering potential new biomarkers for fibrotic liver injury. These findings advance our understanding of shared fibrotic mechanisms.
Area of Science:
- Genomics and transcriptomics
- Liver disease research
- Biomarker discovery
Background:
- Chronic liver diseases (metabolic, viral) often lead to fibrosis and cirrhosis.
- Shared fibrotic mechanisms across etiologies are not fully understood.
Purpose of the Study:
- To identify shared transcriptional programs in liver fibrosis across different etiologies.
- To define a strategy for prioritizing conserved hub genes.
- To identify candidate biomarkers for fibrotic liver injury.
Main Methods:
- Integrated analysis of four public transcriptomic datasets (NAFLD, HBV, mixed, cirrhosis).
- Differential expression analysis, cross-dataset gene intersection, WGCNA, and random forest modeling.
- Validation of seven hub genes using RT-qPCR and western blotting.
Main Results:
- Identified 26 consistently upregulated genes across all etiologies, with enrichment in ECM organization and key signaling pathways (TGF-β, PI3K-Akt, MAPK, Wnt).
- Defined a seven-gene panel (MAOA, LOC102724200, SLC16A3, GPM6B, CST7, MT3, ZNF142) as hub genes.
- Validated upregulation of these seven genes in fibrotic liver tissues.
Conclusions:
- Identified shared and etiology-specific transcriptional programs in liver fibrosis.
- The seven validated hub genes are promising candidate biomarkers for fibrotic liver injury.
- The developed workflow can support future cross-platform transcriptomic studies in hepatic fibrosis.
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:09Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...